
EMPE Diagnostics launched the mf10Dx MDR-TB test kit in Hyderabad, India, to address the public health problem of tuberculosis (TB). The kit, recognized by the World Health Organization (WHO) and approved by CDSCO in India, provides rapid and accurate results on the presence of Mycobacterium tuberculosis and its genotypic resistance profile within three hours. Developed and manufactured in Genome Valley, Telangana, the kit combines molecular and sensitive lateral flow biosensors to detect TB bacteria and identify antibiotic resistance. With a production capacity of 25 million kits, EMPE aims to expand to 100 million kits, emphasizing the importance of early and accurate TB diagnosis.
Like
Save
Share